Skip to main content
VCbacked
Log inGet Started

Heidelberg Epignostix

Heidelberg, Germany

Heidelberg Epignostix is a pioneering start-up led by a dedicated team of DNA methylation-based tumor categorization experts.

$4.6M raised
Jul 2024
Seed
HospitalMedicalWellness

Top Investors

HTGF (High-Tech Gruenderfonds)Carma FundStart-up BW Innovation FondsLBBW VC

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Heidelberg Epignostix

How much funding has Heidelberg Epignostix raised?
Heidelberg Epignostix has raised $4.6M in total funding. The most recent round was Seed. The last funding was announced in July 2024.
Who are Heidelberg Epignostix's investors?
Heidelberg Epignostix's investors include HTGF (High-Tech Gruenderfonds), Carma Fund, Start-up BW Innovation Fonds, LBBW VC.
Where is Heidelberg Epignostix headquartered?
Heidelberg Epignostix is headquartered in Heidelberg, Germany.
What does Heidelberg Epignostix do?
Heidelberg Epignostix is a pioneering start-up led by a dedicated team of DNA methylation-based tumor categorization experts.
What stage is Heidelberg Epignostix at?
Heidelberg Epignostix is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Heidelberg Epignostix — Funding & Investors." VCBacked, July 2, 2024, https://www.vcbacked.co/company/heidelberg-epignostix. Accessed June 17, 2026.
APA
VCBacked. (2024). Heidelberg Epignostix — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/heidelberg-epignostix
Wikipedia (cite web)
{{cite web |title=Heidelberg Epignostix — Funding & Investors |url=https://www.vcbacked.co/company/heidelberg-epignostix |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Hospital

View all
Dishio
Miami
Smartness
Riva Del Garda$14.3M
Culturewell
Ann Arbor$1.4M
Triomics
San Francisco
Kin Health
Los Angeles
Aumet
Mountain View